Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Plymate

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
JAMA Oncology|June 30, 2018
Nuclear Circulating Tumor Cell Androgen Receptor Variant 7 in Castration-Resistant Prostate Cancer: The Devil Is in the DetailStephen R Plymate, Adam Sharp, Johann S de Bono
International Journal of Cancer|February 26, 2011
Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progressionCynthia C Sprenger, Stephen R Plymate, May J Reed
Cancer Cell|February 12, 2015
Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2Stephen R Plymate, Rupal S Bhatt, Steven P Balk
American Journal of Physiology. Endocrinology and Metabolism|October 18, 2007
Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signalingLebris S Quinn, Barbara G Anderson, Stephen R Plymate
Experimental Cell Research|March 27, 2010
Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor geneHagit Schayek, Itay Bentov, Shihua Sun, et al.
Biomaterials|June 20, 2014
Prostate cancer xenografts engineered from 3D precision-porous poly(2-hydroxyethyl methacrylate) hydrogels as models for tumorigenesis and dormancy escapeThomas J Long, Cynthia C Sprenger, Stephen R Plymate, et al.
The Prostate|April 12, 2002
Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivoGayathri R Devi, Cynthia C Sprenger, Stephen R Plymate, et al.
Oncogene|January 16, 2002
Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosisCynthia C Sprenger, Mary E Vail, Karen Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formationJennifer D Wu, Catherine L Atteridge, Xuanjun Wang, et al.
Molecular and Cellular Endocrinology|April 27, 2010
Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cellsHagit Schayek, Hila Seti, Norman M Greenberg, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
JAMA Oncology|June 30, 2018
Nuclear Circulating Tumor Cell Androgen Receptor Variant 7 in Castration-Resistant Prostate Cancer: The Devil Is in the DetailStephen R Plymate, Adam Sharp, Johann S de Bono
International Journal of Cancer|February 26, 2011
Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progressionCynthia C Sprenger, Stephen R Plymate, May J Reed
Cancer Cell|February 12, 2015
Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2Stephen R Plymate, Rupal S Bhatt, Steven P Balk
American Journal of Physiology. Endocrinology and Metabolism|October 18, 2007
Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signalingLebris S Quinn, Barbara G Anderson, Stephen R Plymate
Experimental Cell Research|March 27, 2010
Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor geneHagit Schayek, Itay Bentov, Shihua Sun, et al.
Biomaterials|June 20, 2014
Prostate cancer xenografts engineered from 3D precision-porous poly(2-hydroxyethyl methacrylate) hydrogels as models for tumorigenesis and dormancy escapeThomas J Long, Cynthia C Sprenger, Stephen R Plymate, et al.
The Prostate|April 12, 2002
Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivoGayathri R Devi, Cynthia C Sprenger, Stephen R Plymate, et al.
Oncogene|January 16, 2002
Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosisCynthia C Sprenger, Mary E Vail, Karen Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formationJennifer D Wu, Catherine L Atteridge, Xuanjun Wang, et al.
Molecular and Cellular Endocrinology|April 27, 2010
Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cellsHagit Schayek, Hila Seti, Norman M Greenberg, et al.
Pageof 12